Swimming into the future of drug discovery: In vivo chemical screens in zebrafish

ACS Chemical Biology

Volumn 5, Issue 2, 2010, Pages 159-161

  Bowman, Teresa V ^a   Zon, Leonard I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DORSOMORPHIN; LDN 193189; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR;

DRUG INHIBITION; DRUG MECHANISM; DRUG SCREENING; EMBRYO DEVELOPMENT; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; ZEBRA FISH;

ANIMALS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; SMALL MOLECULE LIBRARIES; ZEBRAFISH;

DANIO RERIO;

EID: 77449155155     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb100029t     Document Type: Short Survey

References (10)

1. van der Greef, J., and McBurney, R. N. (2005) Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology, Nat. Rev. Drug Discovery 4, 961-967.
2. Vernon, J. A., Golec, J. H., and Dimasi, J. A. (2009) Drug development costs when financial risk is measured using the Fama-French three-factor model, Health Econ. Epub ahead of print Aug 4, 2009; DOI: 10.1002/hec.1538.
3. Hao, J., Ho, J., Lewis, J., Karim, K., Daniels, R., Gentry, P., Hopkins, C., Lindsley, C., and Hong, C. (2010) In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors, ACS Chem. Biol. 4, DOI: 10.1021/cb9002865.
4. Yu, P. B., Deng, D. Y., Lai, C. S., Hong, C. C., Cuny, G. D., Bouxsein, M. L., Hong, D. W., McManus, P. M., Katagiri, T., Sachidanandan, C., Kamiya, N., Fukuda, T., Mishina, Y., Peterson, R. T., and Bloch, K. D. (2008) BMP type I receptor inhibition reduces heterotopic [corrected] ossification, Nat. Med. 14, 1363-1369.
5. Zon, L. I., and Peterson, R. T. (2005) In vivo drug discovery in the zebrafish, Nat. Rev. Drug Discovery 4, 35-44.
6. Hammerschmidt, M., Serbedzija, G. N., and McMahon, A. P. (1996) Genetic analysis of dorsoventral pattern formation in the zebrafish: requirement of a BMP-like ventralizing activity and its dorsal repressor, Genes Dev. 10, 2452-2461.
7. Klahr, S. (2003) The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function, J. Nephrol. 16, 179-185.
8. Cuny, G. D., Yu, P. B., Laha, J. K., Xing, X., Liu, J. F., Lai, C. S., Deng, D. Y., Sachidanandan, C., Bloch, K. D., and Peterson, R. T. (2008) Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors, Bioorg. Med. Chem. Lett. 18, 4388-4392.
9. Milan, D. J., Peterson, T. A., Ruskin, J. N., Peterson, R. T., and MacRae, C. A. (2003) Drugs that induce repolarization abnormalities cause bradycardia in zebrafish, Circulation 107, 1355-1358.
10. North, T. E., Goessling, W., Walkley, C. R., Lengerke, C., Kopani, K. R., Lord, A. M., Weber, G. J., Bowman, T. V., Jang, I. H., Grosser, T., Fitzgerald, G. A., Daley, G. Q., Orkin, S. H., and Zon, L. I. (2007) Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis, Nature 447, 1007-1011.